Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Abionyx Pharma |
10/11 | 1,642 EUR
+3,27% |
+3,27% |
|
Abivax |
10/11 | 80,300 EUR
+3,35% |
+3,35% |
Acadia Pharmaceuticals Inc |
10/11 | 18,280 USD
+10,79% |
+10,79% |
|
Achieve Life Sciences Inc. |
9/11 | 6,780 USD
+0,89% |
+0,89% |
|
Actelis Networks Inc |
9/11 | 0,038 USD
-15,71% |
-15,71% |
|
Actinium Pharmaceuticals Inc |
10/11 | 1,570 USD
+1,95% |
+1,95% |
Addex Therapeutics Ltd |
6/11 | 0,023 CHF
+1,77% |
+1,77% |
|
Addex Therapeutics Ltd |
9/11 | 2,790 USD
-3,79% |
-3,79% |
|
Adicet Bio Inc |
9/11 | 2,990 USD
-1,97% |
-1,97% |
|
Aditx Therapeutics Inc |
9/11 | 0,001 USD
-28,57% |
-28,57% |
|
Adma Biologics Inc |
10/11 | 12,670 USD
-0,94% |
-0,94% |
|
Adocia |
10/11 | 3,800 EUR
+25,00% |
+25,00% |
|
Agenus Inc |
10/11 | 7,020 USD
-1,82% |
-1,82% |
|
Agilent Technologies Inc. |
10/11 | 177,880 USD
-1,27% |
-1,27% |
|
Agios Pharmaceuticals Inc |
9/11 | 31,380 USD
+6,70% |
+6,70% |
|
AIM ImmunoTech Inc |
9/11 | 0,157 USD
+1,29% |
+1,29% |
|
Akebia Therapeutics Inc. |
10/11 | 0,542 USD
+1,69% |
+1,69% |
|
Alaunos Therapeutics Inc
|
9/11 | 1,670 USD
-4,02% |
-4,02% |
|
Aldeyra Therapeutics Inc |
10/11 | 0,629 USD
-1,08% |
-1,08% |
|
Alector Inc |
9/11 | 2,460 USD
+7,42% |
+7,42% |
|
Alkermes plc |
9/11 | 46,170 USD
+0,59% |
+0,59% |
|
Allogene Therapeutics Inc |
10/11 | 0,932 USD
-12,08% |
-12,08% |
|
Alnylam Pharmaceuticals Inc |
10/11 | 151,640 USD
-3,17% |
-3,17% |
|
Alterity Therapeutics Ltd |
9/11 | 2,430 USD
0,00% |
0,00% |
|
Amgen |
10/11 | 465,230 USD
0,00% |
0,00% |
|
Amoeba |
9/11 | 0,252 EUR
-1,76% |
-1,76% |
|
AnaptysBio Inc |
10/11 | 48,380 USD
+0,85% |
+0,85% |
|
Anavex Life Sciences Corporation |
10/11 | 1,130 USD
-7,38% |
-7,38% |
|
Anixa Biosciences Inc |
9/11 | 3,160 USD
-0,47% |
-0,47% |
|
Aprea Therapeutics Inc |
6/11 | 0,518 USD
+4,50% |
+4,50% |
|
Aptevo Therapeutics Inc |
10/11 | 1,080 USD
-4,42% |
-4,42% |
|
AquaBounty Technologies Inc |
9/11 | 0,960 USD
-1,84% |
-1,84% |
|
Arbutus Biopharma Corp |
10/11 | 3,820 USD
+2,69% |
+2,69% |
|
Arcus Biosciences Inc |
10/11 | 18,670 USD
-1,48% |
-1,48% |
|
Ardelyx Inc |
10/11 | 3,010 USD
+2,73% |
+2,73% |
|
Armata Pharmaceuticals Inc |
9/11 | 3,800 USD
+8,26% |
+8,26% |
|
Array Technologies Inc |
9/11 | 5,190 USD
-11,36% |
-11,36% |
|
Arrowhead Pharmaceuticals Inc. |
10/11 | 49,000 USD
-0,49% |
-0,49% |
|
Arvinas Inc |
9/11 | 6,760 USD
+5,46% |
+5,46% |
|
Ascendis Pharma A/S |
9/11 | 259,850 USD
+1,18% |
+1,18% |
|
Atara Biotherapeutics Inc |
10/11 | 8,100 USD
-0,98% |
-0,98% |
|
Aurinia Pharmaceuticals Inc |
9/11 | 16,620 USD
+0,97% |
+0,97% |
|
Autolus Therapeutics plc |
10/11 | 1,320 USD
0,00% |
0,00% |
Avacta Group Plc |
9/11 | 53,400 GBX
-0,74% |
-0,74% |
Avicanna Inc |
6/11 | 0,105 CAD
0,00% |
0,00% |
|
Avidity Biosciences Inc |
9/11 | 8,380 USD
+0,48% |
+0,48% |
|
AVITA Medical Inc |
9/11 | 17,120 USD
+3,19% |
+3,19% |
|
Axon Enterprise Inc |
10/11 | 302,540 USD
-0,21% |
-0,21% |